文献速递肥胖与代谢综合征糖尿病

脂肪因子与代谢健康随时间转变的关联:社区动脉粥样硬化风险(ARIC)研究

Adipokines and Transitions in Metabolic Health Over Time: The Atherosclerosis Risk In Communities (ARIC) Study.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

在8423名参加ARIC第2次(1990-1992)和第4次(1996-1998)随访的成年人中,评估第2次随访时脂联素和瘦素水平(每升高1个标准差)与6年代谢健康状态转变的前瞻性关联。脂联素升高与从代谢健康进展为不健康的风险降低相关(OR 0.53,95%CI:0.48-0.57),而瘦素升高则增加该风险(OR 2.22,95%CI:2.01-2.47);脂联素升高与从代谢不健康回归健康相关(OR 1.58,95%CI:1.42-1.76),瘦素升高则降低回归可能性(OR 0.68,95%CI:0.60-0.78)。

要点

  • 脂联素每升高1个标准差,6年内从代谢健康进展为不健康的OR为0.53(95%CI:0.48-0.57)。
  • 瘦素每升高1个标准差,6年内从代谢健康进展为不健康的OR为2.22(95%CI:2.01-2.47)。
  • 脂联素每升高1个标准差,从代谢不健康回归健康的OR为1.58(95%CI:1.42-1.76);瘦素则为OR 0.68(95%CI:0.60-0.78)。

原文

CONTEXT: Transitions in metabolic health status over time are strongly linked to risk for cardiovascular events, particularly among individuals with obesity. Adipokines are proteins with metabolic effects, but their role in transitions in metabolic health status over time is unknown. OBJECTIVE: To evaluate the associations of adiponectin and leptin with metabolic risk transitions over time. METHODS: Among 8423 individuals who attended ARIC Visits 2 (1990-1992) and 4 (1996-1998), we evaluated prospective associations of Visit 2 levels of the adipokines adiponectin and leptin (per 1-SD higher) with 6-year transitions in metabolic health. Metabolic health was categorized as metabolically "healthy" [no metabolic syndrome (MetS) or diabetes], unhealthy (MetS present) without diabetes, or unhealthy with diabetes. Analyses were performed overall and stratified by obesity [body mass index (BMI) ≥ 30 kg/m2]. RESULTS: At Visit 2, the mean age was 58, with 56% female and 21% Black adults. Adults with 1-SD higher adiponectin were less likely to progress from metabolically healthy to unhealthy status over 6 years [odds ratio (OR) 0.53, 95% confidence interval (CI): 0.48-0.57], while those with higher leptin were more likely to progress (OR 2.22, 95% CI: 2.01-2.47). Conversely, those with 1-SD higher adiponectin were more likely to regress from metabolically unhealthy to healthy status (OR 1.58, 95% CI: 1.42-1.76), while those with higher leptin were less likely to regress (OR 0.68, 95% CI: 0.60-0.78). Similar patterns were seen across obesity strata. After adjustment for BMI, associations of adiponectin with metabolic transitions were similar, whereas associations for leptin were significantly attenuated. CONCLUSION: Leptin and adiponectin are differentially linked to the likelihood of worsening and improving metabolic health over time. Adipokines should be explored as targets to improve metabolic health and decrease the risk of future cardiovascular events.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ozkan B, Zhang S, Echouffo-Tcheugui JB, et al. Adipokines and Transitions in Metabolic Health Over Time: The Atherosclerosis Risk In Communities (ARIC) Study. J Clin Endocrinol Metab. 2025. PMID: 39761818. doi:10.1210/clinem/dgae916

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。